Signaling, Hematopoiesis and Mechanisms of Oncogenesis team is pleased to announce theaward of ANR funding for an ambitious research project entitled “Links between CDK6 and extracellular vesicles”. This project aims to explore the non-canonical functions of the CDK6 protein kinase, known primarily for its role in the cell cycle, but with other functions yet to be discovered.

One of the central objectives is to develop new leukemia models, which will provide a better understanding of disease mechanisms. In parallel, the project will evaluate innovative treatments, combining these approaches with the repositioning of CDK6 inhibitors, a promising strategy for improving current therapies.

This research combines fundamental discoveries with potential clinical applications, paving the way for a better understanding and management of leukemias. We thank the ANR for its support and look forward to sharing the progress of this exciting project in the coming months.